DIVA Laboratories, Ltd. (4153.TWO)

TWD 38.75

(-1.77%)

Net Debt Summary of DIVA Laboratories, Ltd.

  • DIVA Laboratories, Ltd.'s latest annual net debt in 2023 was -534.39 Million TWD , down -52.97% from previous year.
  • DIVA Laboratories, Ltd.'s latest quarterly net debt in 2024 Q2 was -601.4 Million TWD , down -3.97% from previous quarter.
  • DIVA Laboratories, Ltd. reported annual net debt of -346.08 Million TWD in 2022, down -15.8% from previous year.
  • DIVA Laboratories, Ltd. reported annual net debt of -298.86 Million TWD in 2021, up 7.53% from previous year.
  • DIVA Laboratories, Ltd. reported quarterly net debt of -546.19 Million TWD for 2024 Q3, up 10.11% from previous quarter.
  • DIVA Laboratories, Ltd. reported quarterly net debt of -578.47 Million TWD for 2024 Q1, down -8.25% from previous quarter.

Annual Net Debt Chart of DIVA Laboratories, Ltd. (2023 - 2019)

Historical Annual Net Debt of DIVA Laboratories, Ltd. (2023 - 2019)

Year Net Debt Net Debt Growth
2023 -534.39 Million TWD -52.97%
2022 -346.08 Million TWD -15.8%
2021 -298.86 Million TWD 7.53%
2020 -323.21 Million TWD 36.2%
2019 -506.63 Million TWD 0.0%

Peer Net Debt Comparison of DIVA Laboratories, Ltd.

Name Net Debt Net Debt Difference
BIONET Corp. -193.47 Million TWD -176.203%
Genetics Generation Advancement Corp. -79.18 Million TWD -574.883%
Welgene Biotech Co.,Ltd. -33.78 Million TWD -1481.84%
Puriblood Medical Co., Ltd. -65.84 Million TWD -711.642%
TFBS Bioscience Inc. -797.57 Million TWD 32.998%